How to Avoid Patent Cliffs: Product Hopping in the Pharma Sector

In May 2015, Mylan Pharmaceuticals appealed to the Third Circuit after the lower court dismissed its case against … Continue Reading

Amgen sues Sandoz over biosimilar application

On October 24, 2014, Amgen filed a complaint against Sandoz, the generic arm of Novartis Group, asserting three … Continue Reading